Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E
  • 10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242
  • 9/25/2025SystImmune to Unveil New Clinical Data on Two ADC Programs at ESMO 202...
  • 9/24/2025NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric Cancer
  • 9/24/2025Fosun Kairui Submits Marketing Application for Brexucabtagene Autoleuc...
  • 9/23/2025Leads Biolabs' LBL-047 Wins FDA Clearance, Advances Toward Clinical Tr...
  • 9/23/2025KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb CM336
  • 9/23/2025IASO Bio Presents 36-Month Data for Fucaso
  • 9/22/2025Ascletis' ASC47 Combined with Semaglutide Shows Superior Weight Loss a...
  • 9/22/2025MagicRNA Publishes First-in-Human Data for In Vivo CAR-T Therapy in SL...
  • 9/22/2025Leads Biolabs Wins FDA Clearance for IND of LBL-047
  • 9/22/2025Marengo Launches Combined Phase II Trial of Invika and Trodelvy in Met...
  • 9/20/2025Ascletis and Sagimet's Acne Drug Demonstrates Rapid Efficacy in Chines...
  • 9/19/2025Lilly/Innovent's Mazdutide Approved in China for Type 2 Diabetes Glyce...
  • 9/18/2025CTTQ Launches Phase 3 Trial for TQB2868 in Metastatic Pancreatic Cance...
  • 9/18/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study o...
  • 9/16/2025Lion TCR Wins FDA Approval to Advance TCR-T Therapy for Chronic HepB
  • 9/15/2025CSPC Receives Approval for Parkinson's Disease Drug Trial in China
  • 9/15/2025Hengrui Files PCT Patent for Novel Amylin Analog with Dual Receptor Ac...
  • 9/15/2025Akeso's Cadonilimab and Pulocimab Combo Shows Promise in IO-Resistant ...
  • 9/13/2025Denovo's Publishes Landmark Trial in Precision Psychiatry in JAMA
  • 9/12/2025China Approves FirboX's Fibroblast-Based Therapy for Clinical Trials
  • 9/11/2025Novartis Gains Expanded Approval for Tabrecta in China
  • 9/11/2025Henlius' HLX43 Shows Promising Results in Phase I Trial
  • 9/11/2025IDEAYA's IDE849 Shows Strong Results in Phase I Trial
  • 9/9/2025RemeGen's Telitacicept Advances in Sjögren's Syndrome
  • 9/9/2025BioNTech and BMS Report Promising Global Phase II Data for Pumitamig
  • 9/8/2025Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...
  • 9/8/2025Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...
  • 9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...
  • Page:10/22 Total number of articles:647: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group